For the treatment of flea and tick infestations in dogs.

This veterinary medicinal product provides immediate and persistent killing activity for 1 month for fleas (Ctenocephalides felis and C. canis) and ticks (Rhipicephalus sanguineus, Ixodes ricinus, I. hexagonus and Dermacentor reticulatus).

Fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.

For oral use.

The veterinary medicinal product should be administered in accordance with the following table to ensure a dose of 20 to 43 mg lotilaner/kg bodyweight.

For dogs of more than 45 kg body weight, use an appropriate combination of available strengths to achieve the recommended dose of 20–43 mg/kg. Underdosing could result in ineffective use and may favour resistance development. To ensure a correct dosage, body weight should be determined as accurately as possible. AdTab is a palatable chewable flavoured tablet. Administer the chewable tablet(s) monthly with or after food. For optimal control of flea and tick infestation, the product should be administered at monthly intervals throughout the flea and/or tick seasons, based on local epidemiological situations.

Not applicable.

Target species: Dogs

1 Mild and transient 2 Typically resolve without treatment 3 Transient in most cases

Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing

authorisation holder or the national competent authority via the national reporting system. See section ‘Contact details’ of the package leaflet.